2026 NPPES data Pediatric Endocrinology Physician NPI 1144214990 MD
Verify on CMS →

BERNARD DEGNAN, MD

Pediatric Endocrinology Physician in ROYAL OAK, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
98
Medicare Part D claims · Pediatric Endocrinology Physician avg: 151
Generic prescribing
51%
generic claims · 49% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$22.05
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

BERNARD DEGNAN, MD filed 98 Medicare Part D claims in 2023 as a Pediatric Endocrinology Physician in ROYAL OAK, Michigan, prescribing 51% generic.

98
Part D claims, 2023
51%
generic prescribing
$22.05
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

BERNARD DEGNAN, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

98 0th percentile higher than 0% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

BERNARD DEGNAN, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about BERNARD DEGNAN, MD?

Quality data not reported

NPI registry status

Active

Issued 09/08/2005

NPI 1144214990

Primary specialty

Pediatric Endocrinology Physician

Niche

1,457 US NPIs in this specialty

Medicare Part D claims

98 35% vs specialty avg

2023 prescription claims

Specialty avg: 151

Specialty distribution in Michigan

How Pediatric Endocrinology Physician compares to other specialties among Michigan providers

Michigan providers

Pediatric Endocrinology Physician share within Michigan

1. Pediatric Endocrinology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pediatric Endocrinology Physician share within Michigan

Specialty board-certification context

Estimated specialty board-certified rate — Pediatric Endocrinology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pediatric Endocrinology Physician ABMS/AOA estimate

Est. board-certified rate (Pediatric Endocrinology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pediatric Endocrinology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

BERNARD DEGNAN, MD appears in the CMS NPPES registry as a Pediatric Endocrinology Physician provider holding MD credentials at 3535 W 13 MILE RD # 707, ROYAL OAK, MI, 48073, with a listed phone of (248) 551-0487. NPI 1144214990 was issued on 09/08/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DEGNAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 98 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $33K in drug spend, split 49% brand-name and 51% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pediatric Endocrinology Physician is a narrow specialty nationwide, with 1,457 enrolled providers across 51 states and an average of 151 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3535 W 13 MILE RD # 707
ROYAL OAK, MI 48073

Provider Details

NPI 1144214990
Specialty Pediatric Endocrinology Physician
Credentials MD
Gender Male
NPI Issued 09/08/2005

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BERNARD DEGNAN, MD. Source: openpaymentsdata.cms.gov.

Total received

$22

Largest payer

Tandem Diabetes Care, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Michigan MI-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to BERNARD DEGNAN, MD. To verify BERNARD DEGNAN, MD's current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

BERNARD DEGNAN, MD — brand share 49.0%
Specialty average (est.)

49% brand-name claims vs 51% generic, on 98 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

98
Total Claims
$33K
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
152
Total Day Supply
4,491
Brand vs Generic
49% brand / 51% generic
Brand Drug Cost
$24K
Generic Drug Cost
$9K

Patient Demographics

Average Patient Age
26.1 years
Avg HCC Risk Score
0.89

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What BERNARD DEGNAN, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Metformin Hcl
22
Levothyroxine Sodium
16
Novolin N
Insulin Nph Human Isophane
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pediatric Endocrinology Physician Overview

How BERNARD DEGNAN, MD fits within the Pediatric Endocrinology Physician landscape nationally.

1,457
Pediatric Endocrinology Physician Providers in US
51
States with Pediatric Endocrinology Physician
151
Avg Claims per Provider

BERNARD DEGNAN, MD's 98 claims are below the specialty average of 151.

Nearby Pediatric Endocrinology Physician Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as DEGNAN.

Compare Pediatric Endocrinology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is BERNARD DEGNAN, MD's specialty?
BERNARD DEGNAN, MD specializes in Pediatric Endocrinology Physician and practices in ROYAL OAK, Michigan. Credentials: MD.
How much does BERNARD DEGNAN, MD prescribe under Medicare Part D?
In 2023, BERNARD DEGNAN, MD wrote 98 Medicare Part D claims totaling $33K in drug costs for N/A beneficiaries.
Where is BERNARD DEGNAN, MD located?
BERNARD DEGNAN, MD is located at 3535 W 13 MILE RD # 707, ROYAL OAK, MI, 48073. Phone: (248) 551-0487.
What is BERNARD DEGNAN, MD's NPI number?
BERNARD DEGNAN, MD's National Provider Identifier (NPI) is 1144214990, issued on 09/08/2005.
Does BERNARD DEGNAN, MD prescribe more brand-name or generic drugs?
BERNARD DEGNAN, MD's prescribing is 49% brand-name and 51% generic drugs by claim count, with $24K in brand drug costs.
How many Pediatric Endocrinology Physician providers are there in the US?
There are 1,457 Pediatric Endocrinology Physician providers across 51 states in the US. The average Pediatric Endocrinology Physician provider writes 151 Medicare Part D claims per year.
What drugs does BERNARD DEGNAN, MD prescribe most often?
Based on 2023 Medicare Part D data, BERNARD DEGNAN, MD's most frequently prescribed drugs include Metformin Hcl, Levothyroxine Sodium, Novolin N. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does BERNARD DEGNAN, MD accept Medicare?
BERNARD DEGNAN, MD appears in CMS Medicare data with 98 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify BERNARD DEGNAN, MD's credentials?
BERNARD DEGNAN, MD's NPI is 1144214990 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology